Salivary hypofunction: An update on therapeutic... (2018 study) Skip to main content
Review Gerodontology 2018

Salivary hypofunction: An update on therapeutic strategies.

Salum FG, Medella-Junior FAC, Figueiredo MAZ, Cherubini K, Gerodontology, 2018

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors searched the medical literature for clinical trials of treatments for dry mouth caused by low saliva production and sorted the treatments by how strong the evidence was.

What They Found

This literature review of 25 clinical trials found that pilocarpine and cevimeline had the strongest evidence of benefit for low saliva production, while hyperbaric oxygen had no supporting evidence for this condition. In most of the studies, the number of participants was low and the follow-up times were short. Citric and malic acids increased saliva flow but also raised the risk of tooth erosion and cavities. No controlled clinical trials supported acupuncture, stem cell therapy or gene therapy, although clinical observations suggested a promising effect. The abstract also found no evidence supporting salivary substitutes, chewing gum or bethanechol.

What This Means for Canadian Patients

For people with dry mouth from low saliva production, this review reports that the best evidence among the treatments it examined was for pilocarpine and cevimeline. It states that there is no evidence supporting hyperbaric oxygen for treating this condition. The abstract does not describe any hyperbaric oxygen protocol, pressure or number of sessions.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

The abstract reports that most of the included studies had few participants and short follow-up times, and it describes the review as a search of one database, MEDLINE/PubMed.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Review
Category Systematic Reviews
Source Pubmed
PubMed ID 29956369
Year Published 2018
Journal Gerodontology
MeSH Terms Acupuncture Therapy; Bethanechol; Chewing Gum; Humans; Hyperbaric Oxygenation; Muscarinic Agonists; Pilocarpine; Quinuclidines; Thiophenes; Xerostomia

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology